Pharmaceutical Reports

Facing patent expirations, pricing pressures, and R&D productivity challenges, pharma companies are relying on market research and consulting services to identify growth opportunities, demonstrate value, and bring innovative therapies to market. This guide provides insights into the pharma consulting landscape.

Report cover

Bacterial Pneumonia Market

Bacterial Pneumonia Market, By Pathogen (Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Pseudomonas aeruginosa, Klebsiella pneumoniae, Chlamydophila pneumoniae, Others), By Testing (Microbial culture, Gram staining, PCR, Immunoassay, Microscopy, Others), By Treatment (Antibiotics, Oxygen therapy, Vaccines, Pain relievers, Cough medicine, Mechanical ventilation, Others), By End-User (Hospitals, Clinics, Diagnostic centers, Research institutes, Others), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More

  • calendar_month Study Period:  2024-2031
  • date_range Base Year:  2023
  • apartment Key Players:  Pfizer, GlaxoSmithKline, Merck, Sanofi, Novartis, Johnson & Johnson
Report cover

Onychomycosis Market

Onychomycosis Market, By Treatment Type (Oral Antifungals, Topical Antifungals, Laser Devices, Photodynamic Therapy, Surgical/Chemical Nail Avulsion, Others), By Route of Administration (Oral, Topical, Injectable, Others), By Distribution Channel (Hospitals & Clinics, Dermatology Centers, Retail & Online Pharmacies, Others), By Infection Type (Distal Subungual Onychomycosis, White Superficial Onychomycosis, Proximal Subungual Onychomycosis, Candidal Onychomycosis, Total Dystrophic Onychomycosis, Others), By Causative Agent (Dermatophytes, Non-Dermatophyte Molds, Yeasts, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More

  • calendar_month Study Period:  2024-2031
  • date_range Base Year:  2023
  • apartment Key Players:  Bayer, Pfizer, Novartis, Johnson & Johnson, Valeant Pharma, Galderma
Report cover

Multiple Myeloma Market

Multiple Myeloma Market, By Drug Class (Immunomodulatory drugs, Proteasome inhibitors, Monoclonal antibodies, Histone deacetylase inhibitors, Immunotherapies), By Route of Administration (Oral, Injectable, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Line of Treatment (Frontline, Second-line, Third-line and beyond), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More

  • calendar_month Study Period:  2024-2031
  • date_range Base Year:  2023
  • apartment Key Players:  Takeda, Janssen, Bristol Myers Squibb, Amgen, Novartis, AbbVie
Report cover

Postoperative Pain Market

Postoperative Pain Market, By Drug Class (Non-steroidal anti-inflammatory drugs (NSAIDs), Opioids, Local anesthetics, Acetaminophen, Nerve blockers), By Route of Administration (Oral, Injection, Topical, Others (transdermal, inhaled, etc.)), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies, Others (clinics, long-term care, etc.)), By Surgery Type (Orthopedic, Obstetric and gynecologic, General, Cardiac, Neurological), By End Use (Hospitals, Clinics, Homecare, Others (ambulatory surgical centers, long-term care centers, etc.)), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More

  • calendar_month Study Period:  2024-2031
  • date_range Base Year:  2023
  • apartment Key Players:  Pfizer, Novartis, Teva Pharmaceutical, Mylan, Allergan, Purdue Pharma
Report cover

Seasonal Influenza Market

Seasonal Influenza Market, By Vaccine Type (Inactivated, Live Attenuated, Recombinant, Others), By Technology (Egg-based, Cell-based, Recombinant, Others), By Age Group (Pediatric, Adult), By Distribution Channel (Hospitals, Clinics, Pharmacies, Others), By Valence (Trivalent, Quadrivalent, Other multivalent), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More

  • calendar_month Study Period:  2024-2031
  • date_range Base Year:  2023
  • apartment Key Players:  GlaxoSmithKline, Sanofi Pasteur, Seqirus, AstraZeneca, Novartis, Abbott
Report cover

Lennox-Gastaut Syndrome (LGS) Market

Lennox-Gastaut Syndrome (LGS) Market, By Drug Class (GABA modulators, Sodium channel blockers, Calcium channel blockers, SV2A modulators, Benzodiazepines, Others), By Route of Administration (Oral, Intravenous, Intranasal, Transdermal, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Age Group (Infants & Toddlers (0 - 2 years), Children (3 - 12 years), Adolescents (13 - 18 years), Adults (>18 years)), By Treatment Type (Monotherapy, Adjunctive/Combination Therapy, Vagus Nerve Stimulation, Ketogenic Diet, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More

  • calendar_month Study Period:  2024-2031
  • date_range Base Year:  2023
  • apartment Key Players:  Eisai, Lundbeck, INSYS Therapeutics, GW Pharmaceuticals, Zogenix
Report cover

WHIM Syndrome Market

WHIM Syndrome Market, By Product Type (Intravenous Immunoglobulin, Subcutaneous Immunoglobulin, Others), By Application (Hypogammaglobulinemia, Neutropenia, Human Papillomavirus Infections, Others), By End-User (Hospitals, Clinics, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More

  • calendar_month Study Period:  2024-2031
  • date_range Base Year:  2023
  • apartment Key Players:  Takeda, CSL Behring, Grifols, Octapharma, ADMA Biologics, Bio Products Laboratory
Report cover

Cell And Gene Therapies In Rare Disorders Market

Cell and Gene Therapies in Rare Disorders Market, By Type of Therapy (Cell Therapy, Gene Therapy, Gene-Modified Cell Therapy), By Disease Indication (Neurological Disorders, Hematological Disorders, Metabolic Disorders, Ophthalmological Disorders, Immunological Disorders, Musculoskeletal Disorders, Others), By Vector Type (Viral Vectors, Non-Viral Vectors), By Cell Type (Hematopoietic Stem Cells, Mesenchymal Stem Cells, Induced Pluripotent Stem Cells, Others), By Route of Administration (Intravenous, Intramuscular, Subretinal, Others), By End-User (Hospitals, Specialty Clinics, Academic and Research Institutes, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions. Show More

  • calendar_month Study Period:  2024-2031
  • date_range Base Year:  2023
  • apartment Key Players:  Novartis AG, Gilead Sciences, Inc., Bluebird Bio, Inc., Spark Therapeutics
Report cover

Adeno-Associated Virus (AAV) Vectors In Gene Therapy Market

Adeno-Associated Virus (AAV) Vectors in Gene Therapy Market, By Vector Type (AAV1, AAV2, AAV5, AAV6, AAV8, AAV9, Others), By Disease Indication (Neurological Disorders, Ophthalmological Disorders, Cardiovascular Disorders, Muscular Disorders, Cancer, Infectious Diseases, Others), By Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide Gene, Deficiency Gene, Others), By Route of Administration (Intravenous, Intramuscular, Subretinal, Intrathecal, Others), By End-User (Hospitals, Clinics, Research Institutes, Pharmaceutical and Biotechnology Companies, Others), By Manufacturing Process (Adherent Cell Culture, Suspension Cell Culture, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More

  • calendar_month Study Period:  2024-2031
  • date_range Base Year:  2023
  • apartment Key Players:  Novartis AG, Gilead Sciences, Inc., Bluebird Bio, Inc., Spark Therapeutics, Inc., Amgen Inc., Sanofi
Report cover

Hemophilia Market

Hemophilia Market, By Product Type (Hemophilia A, Hemophilia B, Inhibitors, Von Willebrand Disease, Others), By Treatment Type (On-demand, Prophylaxis, Extended Half-life Factors, Hemostats, Others), By Therapy (Plasma-derived Factors, Recombinant Factors, Non-factor Replacement, Others), By Age Group (Adults (>18 years), Pediatric (Show More

  • calendar_month Study Period:  2024-2031
  • date_range Base Year:  2023
  • apartment Key Players:  Takeda, CSL Behring, Pfizer, BioMarin, Roche, Novo Nordisk, Sanofi, Bayer